Fenbufen
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H14O3 |
Molar mass | 254.2854 |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Fenbufen |
Articles |
---|
Most recent articles on Fenbufen |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Fenbufen at Clinical Trials.gov Clinical Trials on Fenbufen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Fenbufen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Fenbufen Risk calculators and risk factors for Fenbufen
|
Healthcare Provider Resources |
Causes & Risk Factors for Fenbufen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fenbufen is a non-steroidal anti-inflammatory drug used primarily to treat inflammation in osteoarthritis, ankylosing spondylitis, and tendinitis. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names Cepal, Cinopal, Cybufen, Lederfen, and Reugast. Fenbufen acts by preventing cyclooxygenase from producing prostaglandins which can cause inflammation.